Hamelin Paul 4
4 · SAVIENT PHARMACEUTICALS INC · Filed Sep 20, 2010
Insider Transaction Report
Form 4
Hamelin Paul
President
Transactions
- Award
Common Stock, $0.01 par value per share
2010-09-16$20.27/sh+76,394$1,548,506→ 164,835 total - Tax Payment
Common Stock, $0.01 par value per share
2010-09-16$20.27/sh−34,699$703,349→ 130,136 total
Footnotes (2)
- [F1]The right to receive these shares is pursuant to a performance based restricted stock grant, a portion of which vested on September 16, 2010.
- [F2]These shares were automatically surrendered to the Company pursuant to Rule 16b-3 of the Securities Exchange Act to cover tax withholding obligations in connection with the vesting of performance based restricted stock granted on November 22, 2009.